The Effect of Intrauterine Injection of Granulocyte Stimulant Factor on the Success of Intrauterine Sperm insemination

The Effect of Intrauterine Injection of Granulocyte Stimulant Factor on the Success of Intrauterine Sperm insemination in Patients Referred to Infertility Center of Ardabil University of Medical Sciences

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191122045466N1

Enrollment

Registered

2019-12-18

Start date

2020-01-21

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility

Interventions

Intervention 1: Intervention group: Intrauterine injection of 100 µg G-CSF (Recpharma product) during IUI. Intervention 2: Control group: Perform IUI without intrauterine G-CSF injection.

Eligibility

Sex/Gender

Female

Age

No minimum to 40 Years

Inclusion criteria

Inclusion criteria: Infertility

Exclusion criteria

Exclusion criteria: Endometriosis Uterine Surgery History

Design outcomes

Primary

Measure	Time frame
Pregnancy. Timepoint: 3 weeks after intervention. Method of measurement: Sonography.	—

Secondary

Measure	Time frame
Human chorionic gonadotropin hormone. Timepoint: Two weeks after intervention. Method of measurement: Laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Mostafavirad

Ardabil University of Medical Sciences

e.mostafavirad@arums.ac.ir+98 45 3324 8888

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026